ArticleHuman vaccines & immunotherapeutics2025
A report for the fifth International Workshop on Rotavirus and Norovirus in China.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The fifth International Workshop on Rotavirus and Norovirus in China was convened in Shanghai May 8-9, 2024. The workshop was organized by Fudan University and China Center for Disease Control and Prevention (China CDC), with strong support from Bill & Melinda Gates Foundation and the Centers for Disease Control and Prevention in the United States (US CDC). Over 230 participants from 10 countries, including experts and representatives from government and non-government organizations, academia and vaccine manufacturers, attended the meeting. Progress on reduced rotavirus disease burden, the impact of currently licensed oral vaccines, new vaccines and technologies under development to control and prevent acute gastroenteritis caused by rotavirus and norovirus, mucosal immunity and its measurement, as well as the association between the effectiveness of rotavirus vaccine and intestinal microbiome were discussed extensively. This report summarized the latest information shared at the convening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.